Glen Tullman is CEO of Livongo Health, which has developed a connected device called In Touch that helps diabetics monitor blood sugar levels and share data with family members or their doctor.
Livongo announced in April 2016 that it had raised $44.5 million in Series C funding.
Tullman is also managing partner of 7wire Ventures, executive chairman of Argo Tea and the former CEO of electronic health record company Allscripts. During his 15-year watch at Allscripts, the company went public and grew from an annual revenue of about $30 million to $1.4 billion.
After leaving Allscripts and focusing on investing, Tullman launched Livongo Health in late 2014. He told the Tribune that both his son and his niece have Type 1 diabetes, and that spurred his motivation to run a company again. He serves as a Chancellor to the International Board of the Juvenile Diabetes Research Foundation.
“We all have an obligation to make the world a better place,” he told Blue Sky in an interview about 7wire, which focuses on health- and education-related technology investments. “So giving back is important not only for something to do, but also the kind of people who give back are the kind of people that we want working in our businesses.”
Tullman studied psychology and economics at Bucknell University and has three children. He is the youngest of six children; his oldest sibling, Howard, is outgoing CEO of tech hub 1871.